Journal
PEDIATRIC BLOOD & CANCER
Volume 62, Issue 4, Pages 553-564Publisher
WILEY-BLACKWELL
DOI: 10.1002/pbc.25313
Keywords
brain; chemotherapy; pediatric hematology; oncology; tumours
Categories
Funding
- Cancer Research UK [13457] Funding Source: researchfish
- The Brain Tumour Charity [16/193] Funding Source: researchfish
- Cancer Research UK [13457] Funding Source: Medline
Ask authors/readers for more resources
Effective treatment of children with medulloblastoma requires a functioning multi-disciplinary team with adequate neurosurgical, neuroradiological, pathological, radiotherapy and chemotherapy facilities and personnel. In addition the treating centre should have the capacity to effectively screen and manage any tumour and treatment-associated complications. These requirements have made it difficult for many low and middle-income countries (LMIC) centres to offer curative treatment. This article provides management recommendations for children with standard-risk medulloblastoma (localised tumours in children over the age of 3-5 years) according to the level of facilities available. Pediatr Blood Cancer 2015;62:553-564. (c) 2014 Wiley Periodicals, Inc.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available